New Rotavirus Vaccine is Recommended
Posted on: Tuesday, 21 February 2006, 21:00 CST
The U.S. agency overseeing childhood vaccinations Tuesday recommended a new vaccine for routine use against rotavirus infection.
Rotavirus infections are common childhood illnesses that are the single largest infectious disease killer of infants and young children worldwide. Three scientists associated with The Children's Hospital of Philadelphia and The Wistar Institute are co-inventors of the vaccine, based on research dating to 1980.
Meeting Tuesday in Atlanta, the Advisory Committee on Immunization Practices -- an expert panel selected by the U.S. Department of Health and Human Services -- added the new RotaTeq vaccine, manufactured by Merck & Co. Inc., to its list of routinely recommended childhood immunizations.
The decision follows the vaccine's approval for licensing earlier this month by the U.S. Food and Drug Administration.
Rotavirus affects nearly all children at some point, often with mild symptoms, but in other cases with severe and potentially life-threatening diarrhea and dehydration. It causes tens of thousands of U.S. hospitalizations annually, and around the world, hundreds of thousands of child deaths.
The new vaccine was invented by three Philadelphia scientists, Drs. H. Fred Clark, Paul Offit and Stanley Plotkin.
Source: United Press International
Related Articles
- Physicians More Likely to Vaccinate Their Children for H1N1
- Federal Advisory Committee Votes to Include Newly Licensed Pentacel(R) Vaccine in Vaccines for Children Program
- ROTATEQ(R) and GARDASIL(R) Adopted By All Immunization Projects of the Centers for Disease Control and Prevention's (CDC) Vaccines for Children (VFC) Program
- Singapore Urges Parents to Vaccinate Their Children againstMMR
- Nepali Gov't Provides Vaccines to Children to Reduce Child Mortality
- CDC's Advisory Committee Recommends Expanded Influenza Vaccinations for Children
- CDC Advisory Committee on Immunization Practices Votes to Recommend Inclusion of ROTATEQ(R) in the Vaccines for Children (VFC) Program
- Vaccine Against Children Diarrhea Wins FDA Approval
- The Association Between Having a Medical Home and Vaccination Coverage Among Children Eligible for the Vaccines for Children Program
- Effectiveness of the 2003-2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 Vs 2 Doses
 |
 |
User Comments (0)
RSS Feeds